These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 16219807)
21. On the importance and mechanism of amplification of digitalis signal through Na+/K+-ATPase. Liu L; Askari A Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):28-30. PubMed ID: 17535733 [TBL] [Abstract][Full Text] [Related]
22. A review of the actions and interactions of drugs used in the treatment of cardiovascular disease. Rubel RL N Y State Dent J; 1975 Apr; 41(4):211-4. PubMed ID: 1054808 [No Abstract] [Full Text] [Related]
24. [Milestones of cardiovascular pharmacotherapy: II. Digitalis]. Jerie P Cas Lek Cesk; 2007; 146(4):314-20. PubMed ID: 17491240 [TBL] [Abstract][Full Text] [Related]
25. Simplified digitalis-like compounds acting on Na(+), K(+)-ATPase. Cerri A; Gobbini M J Enzyme Inhib Med Chem; 2003 Aug; 18(4):289-95. PubMed ID: 14567542 [TBL] [Abstract][Full Text] [Related]
26. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure. Erdmann E; Schwinger R; Böhm M J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118 [TBL] [Abstract][Full Text] [Related]
27. [The digitalis: should we forget it?]. Greco S; Antonini L; Auriti A; Leone F; Santini M G Ital Cardiol (Rome); 2008 Jul; 9(7):482-90. PubMed ID: 18678214 [TBL] [Abstract][Full Text] [Related]
28. Digitalis structure-activity relationship analyses. Conclusions from indirect binding studies with cardiac (Na+ + K+)-ATPase. Brown L; Erdmann E; Thomas R Biochem Pharmacol; 1983 Sep; 32(18):2767-74. PubMed ID: 6313008 [TBL] [Abstract][Full Text] [Related]
29. [Congestive cardiomyopathy: basal hemodynamics and hemodynamics after various positive inotropic drugs administered singly or in combinations]. Cappello C; Fusaro MT; Mattioli G Cardiologia; 1988 Dec; 33(12):1127-32. PubMed ID: 3076518 [No Abstract] [Full Text] [Related]
30. Digitalis Investigation Group (DIG) trial: a stimulus for further research. Gheorghiade M; Pitt B Am Heart J; 1997 Jul; 134(1):3-12. PubMed ID: 9266777 [No Abstract] [Full Text] [Related]
31. Subcellular mechanisms underlying digitalis-induced arrhythmias: role of calcium/calmodulin-dependent kinase II (CaMKII) in the transition from an inotropic to an arrhythmogenic effect. Gonano LA; Petroff MV Heart Lung Circ; 2014 Dec; 23(12):1118-24. PubMed ID: 25201479 [TBL] [Abstract][Full Text] [Related]
33. Digitalis and the Na+,K(+)-ATPase. Medford RM Heart Dis Stroke; 1993; 2(3):250-5. PubMed ID: 8137034 [TBL] [Abstract][Full Text] [Related]
34. In search of the digitalis replacement. Erhardt PW J Med Chem; 1987 Feb; 30(2):232-7. PubMed ID: 3027335 [TBL] [Abstract][Full Text] [Related]
35. [New inotropic drugs]. Ferrari M; Cargnelli G; Piovan D; Bova S; Padrini R G Ital Cardiol; 1982; 12(2):139-46. PubMed ID: 6293904 [No Abstract] [Full Text] [Related]
36. Cardiotoxicity of digitalis glycosides: roles of autonomic pathways, autacoids and ion channels. Demiryürek AT; Demiryürek S Auton Autacoid Pharmacol; 2005 Apr; 25(2):35-52. PubMed ID: 15757504 [TBL] [Abstract][Full Text] [Related]
37. [Use and mechanism of action of digitalis glycosides as anti-arrhythmic drugs]. Nadeau R Acta Cardiol; 1977; Suppl 22():97-105. PubMed ID: 301694 [TBL] [Abstract][Full Text] [Related]